Seasonal Influenza Vaccine Supply (Adults Under 65)

The contract entails the supply of 2,000 units of Flucelvax TIV 0.5mL prefilled syringes intended for adult employees under 65 years of age, with a mandatory delivery deadline of September 1, 2026. The agreement is classified as a subcontract under NAICS code 325412, which pertains to pharmaceutical preparations manufacturing, and is administered by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. Performance is to occur in Silver Spring, Maryland, with the zip code 20993, indicating the location where the vaccine will be deployed or managed upon delivery. Bids must be submitted by July 6, 2026, at 2:00 PM, and the solicitation was posted on June 17, 2026, providing vendors a roughly four-week window to respond. The contract does not specify any set-aside provisions or small business preferences, and no point of contact information is included. The syringes are prefilled, ensuring ease of administration and compliance with workplace immunization protocols for non-elderly adult personnel. Delivery timing is critical to align with seasonal influenza campaign requirements, and the product must meet all regulatory and quality standards applicable to influenza vaccines distributed in the United States.